SCHEMBL30937107

SCHEMBL30937107

CCc1cc(Nc2ncc(Cl)c(Nc3ccc(OC)cc3NS(C)(=O)=O)n2)c(OC)cc1N1CCC(N)CC1

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.67
▸ LRRK2 Q5S007 1/20 0.54
▸ ROS1 P08922 1/20 0.52
▸ ALK Q9UM73 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30936957 0.92 EGFR (0.67) EGFRLRRK2ROS1ALK
SCHEMBL27076077 0.89 EGFR (0.60) EGFRLRRK2ALK
SCHEMBL30936763 0.89 EGFR (0.69) EGFR
SCHEMBL26906593 0.87 EGFR (0.69) EGFRALK
SCHEMBL27076074 0.87 EGFR (0.65) EGFRLRRK2ROS1ALK
SCHEMBL30936825 0.85 EGFR (0.60) EGFRLRRK2
SCHEMBL30936805 0.85 EGFR (0.72) EGFRALK
SCHEMBL30936784 0.85 EGFR (0.62) EGFRALK
SCHEMBL27076022 0.83 EGFR (0.69) EGFRLRRK2ROS1ALK
SCHEMBL27076147 0.82 EGFR (0.70) EGFRALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072178-A1 COMPOUND FOR TARGETED PROTEIN DEGRADATION, AND USE THEREOF (주)사이러스테라퓨틱스 2024-04-04 — — WO disclosed
Send feedback